- Home
- MDGL vs MMYT Comparison
MDGL vs MMYT Comparison
Compare MDGL & MMYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- MMYT
- Stock Information
- Founded
- MDGL 2011
- MMYT 2000
- Country
- MDGL United States
- MMYT India
- Employees
- MDGL N/A
- MMYT N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- MMYT Transportation Services
- Sector
- MDGL Health Care
- MMYT Consumer Discretionary
- Exchange
- MDGL Nasdaq
- MMYT Nasdaq
- Market Cap
- MDGL 9.6B
- MMYT 9.0B
- IPO Year
- MDGL N/A
- MMYT 2010
- Fundamental
- Price
- MDGL $423.00
- MMYT $77.12
- Analyst Decision
- MDGL Strong Buy
- MMYT Strong Buy
- Analyst Count
- MDGL 12
- MMYT 3
- Target Price
- MDGL $521.09
- MMYT $120.00
- AVG Volume (30 Days)
- MDGL 277.8K
- MMYT 1.1M
- Earning Date
- MDGL 11-04-2025
- MMYT 10-28-2025
- Dividend Yield
- MDGL N/A
- MMYT N/A
- EPS Growth
- MDGL N/A
- MMYT N/A
- EPS
- MDGL N/A
- MMYT 0.69
- Revenue
- MDGL $515,547,000.00
- MMYT $1,011,011,000.00
- Revenue This Year
- MDGL $394.38
- MMYT $22.86
- Revenue Next Year
- MDGL $64.73
- MMYT $21.38
- P/E Ratio
- MDGL N/A
- MMYT $112.30
- Revenue Growth
- MDGL 3421.98
- MMYT 14.55
- 52 Week Low
- MDGL $213.71
- MMYT $76.45
- 52 Week High
- MDGL $463.63
- MMYT $123.00
- Technical
- Relative Strength Index (RSI)
- MDGL 46.03
- MMYT 22.33
- Support Level
- MDGL $413.82
- MMYT $88.99
- Resistance Level
- MDGL $436.79
- MMYT $92.09
- Average True Range (ATR)
- MDGL 18.12
- MMYT 3.46
- MACD
- MDGL -2.63
- MMYT -1.01
- Stochastic Oscillator
- MDGL 48.76
- MMYT 4.22
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About MMYT MakeMyTrip Limited
MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.